NBEO-BCTM Patient Case Template for Ppms

NBEO-BCTM Patient Case Template for Ppms

<p> NBEO-BCTM Patient Case Template for PPMs </p><p>Demographics age-year-old race gender; occupation Chief complaint xxxxx History of present illness Character/signs/symptoms: xxxxx Location: xxxxx Severity: xxxxx Nature of onset: xxxxx Duration: xxxxx Frequency: xxxxx Exacerbations/remissions: xxxxx Relationship to activity or function: xxxxx Accompanying signs/symptoms: xxxxx Secondary complaints/symptoms xxxxx Patient ocular history xxxxx Family ocular history mother: xxxxx father: xxxxx Patient medical history xxxxx Medications used by patient xxxxx Patient allergy history xxxxx; NKMA Family medical history mother: xxxxx father: xxxxx Review of systems Constitutional/general health: excellent Ear/nose/throat: denies Cardiovascular: denies Pulmonary: denies Endocrine: denies Dermatological: denies Gastrointestinal: denies Genitourinary: denies Musculoskeletal: denies Neurologic: denies Psychiatric: denies Immunologic: denies Hematologic: denies Mental status Orientation: oriented to time, place, and person Mood: appropriate Affect: appropriate Clinical findings BVA: Distance Near OD: 20/xx 20/xx OS: 20/xx 20/xx Pupils: PERRL, negative RAPD EOMs: full, no restrictions Confrontation fields: FTFC OD, OS Slit lamp: lids/lashes/adnexa: unremarkable OD, OS conjunctiva: normal OD, OS cornea: clear OD, OS anterior chamber: deep and quiet OD, OS iris: normal OD, OS lens: clear OD, OS vitreous: clear OD, OS IOPs: xx mmHg OD, xx mmHg OS @ hr:min am/pm by applanation tonometry Fundus OD: C/D: xx H/xx V macula: normal posterior pole: normal periphery: unremarkable Fundus OS: C/D: xx H/xx V macula: normal posterior pole: normal periphery: unremarkable Additional ocular tests: Blood pressure: xxx/xx mmHg, right arm, sitting Pulse: xx bpm, regular Body mass index: xx.x Reference ranges <18.5 underweight 18.5 - 24.9 normal 25.0 - 29.9 overweight >30.0 obese Laboratory tests: Results Reference ranges Glucose xxx mg/dL 65 - 115 (fasting) Urea nitrogen xx mg/dL 5 - 24 Creatinine x.x mg/dL 0.7 - 1.4 Sodium xxx meq/L 136 - 146 Potassium x.x meq/L 3.7 - 5.3 Chloride xxx meq/L 101 - 111 CO2 xx meq/L 21 - 31 Calcium x.x mg/dL 8.5 - 10.2</p><p>Cholesterol xxx mg/dL < 199 Triglyceride xxx mg/dL 30 - 149 HDL xx mg/dL > 40 LDL xxx mg/dL < 130</p><p>HgbA1c x.x% 4.0 - 6.0</p><p>RBC x.xx M/L 4.5 - 5.9 (male) Hgb xx.x g/dL 13.5 - 17.5 (male) Hct xx% 42 - 54 (male) MCV xx fL 80 - 103 MCH xx pg 26 - 34 MCHC xx g/dL 30 - 37 RDW-CV xx.x% 11.5 - 14.5</p><p>WBC x.x K/L 3.9 - 11.0 Neutrophil % xx% 49 - 78 Lymphocyte % xx% 20 - 45 Monocyte % x.x% 3.0 - 9.5 Eosinophil % x.x% 0.0 - 4.0 Basophil % x.x% 0.0 - 3.0 Platelet xxx K/L 130 - 400 MPV xx.x fL 7.4 - 12.0 Additional laboratory tests: Additional non-ocular tests: Ocular images: Case diagnosis: Treatment: </p><p>The PPM Patient Case Content text fields represent where the participant can insert the applicable diagnosis and treatment information)</p><p>ITEM TYPE PPM Patient Case CONTENT</p><p>A: Diagnosis Indicates the most appropriate diagnosis B: Related to Diagnosis Relates to data supporting or correlating with the diagnosis; or the correlation of possible additional data; or indicates additional data or the next test needed C: Treatment / Management Indicates the most appropriate treatment or management D: Related to Treatment / Management Relates to the treatment mechanism; describes additional data needed to treat effectively; indicates additional next test needed; describes patient education; relates to follow-up; or forecasts prognosis</p><p>Modified 9.10.13 JET</p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    3 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us